• Petitioned The Pharmaceutical Benefits Advisory Committee

This petition was delivered to:

The Pharmaceutical Benefits Advisory Committee

Keep dementia drugs on the PBS

    1. Kerri Cross
    2. Petition by

      Kerri Cross

      Toowoomba, Australia

The availability of these drugs donepezil; rivastigmine; galantamine; and memantine are vital to people suffering from dementia and Alzheimer's disease. They are specifically designed for dementia to slow down progression of the disease, as well as ease symptoms. If these drugs are removed from the Pharmaceutical Benefits Scheme (PBS) it will make it very expensive (up to $150 a month) for people to access these medications. We need to be a voice for those unable to speak and keep these medications on the PBS.

Recent signatures

    News

    1. Reached 100 signatures

    Supporters

    Reasons for signing

    • Kelly Collier AUSTRALIA
      • over 1 year ago

      I have 2 x grandparents taking this medication which is imperative to their short term health. There is no way they can afford to remain taking it if it not on the PBS

      REPORT THIS COMMENT:
    • Ronald Creed MINLATON, AUSTRALIA
      • over 1 year ago

      Health is the highest priority.

      REPORT THIS COMMENT:
    • Shelley Steel HENDRA, AUSTRALIA
      • over 1 year ago

      Dementia strikes towards the end of life, when most peoples finances have been mostly used up.

      REPORT THIS COMMENT:
    • Christine O'Hare CABOOLTURE SOUTH, AUSTRALIA
      • over 1 year ago

      With a mother who has dementia I am very concerned at the measures being considered to cut costs.

      REPORT THIS COMMENT:
    • Diana Waygood GIRRAWHEEN WA, AUSTRALIA
      • over 1 year ago

      The members of the commitee should remember that eventually they... or their loved ones... may need these medications.

      REPORT THIS COMMENT:

    Develop your own tools to win.

    Use the Change.org API to develop your own organizing tools. Find out how to get started.